Your browser doesn't support javascript.
loading
Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma.
Tetzlaff, M T; Adhikari, C; Lo, S; Rawson, R V; Amaria, R N; Menzies, A M; Wilmott, J S; Ferguson, P M; Ross, M I; Spillane, A J; Vu, K A; Ma, J; Ning, J; Haydu, L E; Saw, R P M; Wargo, J A; Tawbi, H A; Gershenwald, J E; Long, G V; Davies, M A; Scolyer, R A.
Afiliação
  • Tetzlaff MT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: mtetzlaff@mdanderson.org.
  • Adhikari C; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia.
  • Lo S; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia.
  • Rawson RV; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; New South Wales Health Pathology, Sydney, Australia.
  • Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Menzies AM; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Wilmott JS; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia.
  • Ferguson PM; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; New South Wales Health Pathology, Sydney, Australia.
  • Ross MI; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Spillane AJ; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Vu KA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Ma J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Ning J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Haydu LE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Saw RPM; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia.
  • Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Tawbi HA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Long GV; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.
  • Davies MA; Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Ce
  • Scolyer RA; Melanoma Institute of Australia, The University of Sydney, Sydney, Australia; Royal Prince Alfred Hospital, Sydney, Australia; New South Wales Health Pathology, Sydney, Australia. Electronic address: Richard.Scolyer@health.nsw.gov.au.
Ann Oncol ; 31(11): 1569-1579, 2020 11.
Article em En | MEDLINE | ID: mdl-32739408
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Segunda Neoplasia Primária / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Segunda Neoplasia Primária / Melanoma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article